V VERITY PHARMACEUTICALS Trademark

Trademark Overview


On Wednesday, November 11, 2020, a trademark application was filed for V VERITY PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the V VERITY PHARMACEUTICALS trademark a serial number of 90311864. The federal status of this trademark filing is REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED as of Monday, November 27, 2023. This trademark is owned by Verity Pharmaceuticals Inc.. The V VERITY PHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for use in anesthesiology, cardiology, cardiovascular/thoracic surgery, clinical immunology/allergy, critical care medicine, dermatology, diagnostic radiology, emergency medicine, endocrinology and metabolism, gastroenterology, hematology, medical microbiology and infectious diseases, medical oncology, nephrology, neurology, nuclear medicine, obstetrics/gynecology, ophthalmology, orthopedic surgery, otolaryngology, psychiatry, radiation oncology, respirology, rheumatology, urology
v verity pharmaceuticals

General Information


Serial Number90311864
Word MarkV VERITY PHARMACEUTICALS
Filing DateWednesday, November 11, 2020
Status654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED
Status DateMonday, November 27, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of a stylized letter "V", with the stylized words "VERITY PHARMACEUTICALS" appearing in stacked formation to the right of the "V".
Goods and ServicesPharmaceuticals for use in anesthesiology, cardiology, cardiovascular/thoracic surgery, clinical immunology/allergy, critical care medicine, dermatology, diagnostic radiology, emergency medicine, endocrinology and metabolism, gastroenterology, hematology, medical microbiology and infectious diseases, medical oncology, nephrology, neurology, nuclear medicine, obstetrics/gynecology, ophthalmology, orthopedic surgery, otolaryngology, psychiatry, radiation oncology, respirology, rheumatology, urology
Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"PHARMACEUTICALS"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 11, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVerity Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMississauga, Ontario L4W4Y9
CA

Trademark Events


Event DateEvent Description
Monday, November 27, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, June 30, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, June 30, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 30, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 30, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 30, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, November 28, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, May 19, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, November 18, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, November 18, 2021LETTER OF SUSPENSION E-MAILED
Thursday, November 18, 2021SUSPENSION LETTER WRITTEN
Wednesday, October 27, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 26, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 26, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 26, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 26, 2021NON-FINAL ACTION E-MAILED
Monday, April 26, 2021NON-FINAL ACTION WRITTEN
Wednesday, April 21, 2021ASSIGNED TO EXAMINER
Monday, January 11, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, November 14, 2020NEW APPLICATION ENTERED